TORONTO–(BUSINESS WIRE)–Further to its press release dated April 30, 2019, DionyMed Brands Inc.
(CSE: DYME)(OTC:DMYEF) (“DionyMed” or the “Company”) is
providing an update with respect to the previously announced delay in
the filing of its annual financial statements for the year ended
December 31, 2018 and the management cease trade order (the “MCTO“)
issued by the British Columbia Securities Commission on May 2, 2019. The
MCTO was issued in connection with this delay by the Company in filing
the annual financial statements, and the related management’s discussion
and analysis and officer certifications (collectively, the “Annual
Filings“) beyond the required filing deadline of April 30, 2019.
The Company is working closely with its auditor and continues to expect
to file the Annual Filings on or before May 31, 2019. The Company does
not anticipate any delay in filing its interim financial statements,
management’s discussion and analysis, and the related officer
certifications for the financial period ended March 31, 2019.
On behalf of the Board,
Edward Fields
Chief Executive Officer
About DionyMed
Founded in 2017, DionyMed is a multi-state cannabis brands platform,
supporting cultivators, manufacturers and award-winning brands in the
medical and adult-use cannabis markets. DionyMed sells branded products
in every category from flower to vape cartridges, concentrates and
edibles. DionyMed serves cannabis consumers through retail dispensary
distribution and direct-to-consumer fulfillment with its growing
portfolio of award-winning brands. Learn more at dionymed.com and
follow @DYME_Inc on Twitter and LinkedIn.
Cautionary Statement on Forward-Looking
Statements
The information in this document contains certain forward-looking
statements with respect to activities of the Company, based on
assumptions about future courses of action, including with respect to
the filing of the Annual Filings. Although management has a
reasonable basis for the conclusions drawn, risk factors and
uncertainties may cause actual results to differ materially from those
currently anticipated in such statements. In view of these
uncertainties we caution readers not to place undue reliance on these
forward-looking statements. Statements made in this document are
made as of the date hereof and the Company disclaims any intention or
obligation to update or revise any statements made herein, except in
accordance with applicable securities laws.
Contacts
Edward Fields, CEO
[email protected]
669-232-5270
Peter Kampian, CFO
[email protected]
647-948-8387
Investor
Phil Carlson / Erika Kay
KCSA Strategic
Communications
Phone: (212) 896-1233
Email: [email protected]
/ [email protected]
Media:
Kate Tumino / Brittany Tibaldi
KCSA Strategic
Communications
212-896-1252 / 347-487-6794
[email protected]
/ [email protected]
